日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Imlunestrant, an Oral Selective Estrogen Receptor Degrader, as Monotherapy and in Combination With Targeted Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Phase Ia/Ib EMBER Study

伊姆伦司群(一种口服选择性雌激素受体降解剂)单药治疗及联合靶向治疗在雌激素受体阳性、人表皮生长因子受体2阴性晚期乳腺癌中的疗效:EMBER Ia/Ib期研究

Jhaveri, Komal L; Lim, Elgene; Jeselsohn, Rinath; Ma, Cynthia X; Hamilton, Erika P; Osborne, Cynthia; Bhave, Manali; Kaufman, Peter A; Beck, J Thaddeus; Manso Sanchez, Luis; Parajuli, Ritesh; Wang, Hwei-Chung; Tao, Jessica J; Im, Seock-Ah; Harnden, Kathleen; Yonemori, Kan; Dhakal, Ajay; Neven, Patrick; Aftimos, Philippe; Pierga, Jean-Yves; Lu, Yen-Shen; Larson, Timothy; Jerez, Yolanda; Sideras, Kostandinos; Sohn, Joohyuk; Kim, Sung-Bae; Saura, Cristina; Bardia, Aditya; Sammons, Sarah L; Bacchion, Francesca; Li, Yujia; Yuen, Eunice; Estrem, Shawn T; Rodrik-Outmezguine, Vanessa; Nguyen, Bastien; Ismail-Khan, Roohi; Smyth, Lillian; Beeram, Muralidhar

A Preoperative Window-of-Opportunity Study of Oral SERD, Imlunestrant, in Newly Diagnosed ER-Positive, HER2-Negative Early Breast Cancer: Results from the EMBER-2 Study

一项针对新诊断的ER阳性、HER2阴性早期乳腺癌患者的术前机会窗口研究:口服选择性雌激素受体拮抗剂(SERD)伊姆伦司群的疗效:EMBER-2研究结果

Neven, Patrick; Stahl, Nicole; Vidal, Maria; Martín, Miguel; Kaufman, Peter A; Harbeck, Nadia; Hunt, Kelly K; Carter, Stacey; Bidard, Francois-Clement; Fasching, Peter A; Aftimos, Philippe; Wheatley, Duncan; Hamilton, Erika; Aft, Rebecca; Kulkarni, Swati; Schmid, Peter; Bhave, Manali; Ismail-Khan, Roohi; Karacsonyi, Claudia; Estrem, Shawn T; Nguyen, Bastien; Ozbek, Umut; Yuen, Eunice; Rodrik-Outmezguine, Vanessa; Ciruelos, Eva

Correlates of externalizing psychopathology in incarcerated men

被监禁男性外化心理病理的相关因素

Rodrik, Odile; Weaver, Shelby S; Kiehl, Kent A; Koenigs, Michael

Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS

具有 3 类 BRAF 突变的肿瘤对抑制激活的 RAS 很敏感

Zhan Yao, Rona Yaeger, Vanessa S Rodrik-Outmezguine, Anthony Tao, Neilawattie M Torres, Matthew T Chang, Matthias Drosten, Huiyong Zhao, Fabiola Cecchi, Todd Hembrough, Judith Michels, Hervé Baumert, Linde Miles, Naomi M Campbell, Elisa de Stanchina, David B Solit, Mariano Barbacid, Barry S Taylor, 

Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor

使用新一代 mTOR 抑制剂克服 mTOR 抗性突变

Vanessa S Rodrik-Outmezguine, Masanori Okaniwa, Zhan Yao, Chris J Novotny, Claire McWhirter, Arpitha Banaji, Helen Won, Wai Wong, Mike Berger, Elisa de Stanchina, Derek G Barratt, Sabina Cosulich, Teresa Klinowska, Neal Rosen, Kevan M Shokat

Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin

机制不同的癌症相关 mTOR 激活簇可预测对雷帕霉素的敏感性

Jianing Xu, Can G Pham, Steven K Albanese, Yiyu Dong, Toshinao Oyama, Chung-Han Lee, Vanessa Rodrik-Outmezguine, Zhan Yao, Song Han, David Chen, Daniel L Parton, John D Chodera, Neal Rosen, Emily H Cheng, James J Hsieh

Feedback suppression of PI3Kα signaling in PTEN-mutated tumors is relieved by selective inhibition of PI3Kβ.

PTEN 突变肿瘤中 PI3Kα 信号的反馈抑制可通过选择性抑制 PI3Kβ 来缓解

Schwartz Sarit, Wongvipat John, Trigwell Cath B, Hancox Urs, Carver Brett S, Rodrik-Outmezguine Vanessa, Will Marie, Yellen Paige, de Stanchina Elisa, Baselga José, Scher Howard I, Barry Simon T, Sawyers Charles L, Chandarlapaty Sarat, Rosen Neal

Rapid induction of apoptosis by PI3K inhibitors is dependent upon their transient inhibition of RAS-ERK signaling

PI3K抑制剂快速诱导细胞凋亡依赖于其对RAS-ERK信号通路的短暂抑制。

Will, Marie; Qin, Alice Can Ran; Toy, Weiyi; Yao, Zhan; Rodrik-Outmezguine, Vanessa; Schneider, Claudia; Huang, Xiaodong; Monian, Prashant; Jiang, Xuejun; de Stanchina, Elisa; Baselga, José; Liu, Ningshu; Chandarlapaty, Sarat; Rosen, Neal

mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer

mTORC1 抑制是 PIK3CA 突变乳腺癌对 PI3K p110α 抑制剂敏感的必要条件

Moshe Elkabets, Sadhna Vora, Dejan Juric, Natasha Morse, Mari Mino-Kenudson, Taru Muranen, Jessica Tao, Ana Bosch Campos, Jordi Rodon, Yasir H Ibrahim, Violeta Serra, Vanessa Rodrik-Outmezguine, Saswati Hazra, Sharat Singh, Phillip Kim, Cornelia Quadt, Manway Liu, Alan Huang, Neal Rosen, Jeffrey A E

AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity

AKT 抑制可减轻受体酪氨酸激酶表达和活性的反馈抑制

Sarat Chandarlapaty, Ayana Sawai, Maurizio Scaltriti, Vanessa Rodrik-Outmezguine, Olivera Grbovic-Huezo, Violeta Serra, Pradip K Majumder, Jose Baselga, Neal Rosen